Registry for endovascular treatment of acute ischemic stroke in Germany
German Stroke Registry - Endovascular Treatment
This study is collecting information from patients in Germany who are receiving special procedures for acute ischemic stroke to see how well these treatments work and how safe they are.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg, Free and Hanseatic City of Hamburg) |
| Trial ID | NCT03356392 on ClinicalTrials.gov |
What this trial studies
The German Stroke Registry - Endovascular Treatment is an observational study that enrolls patients treated with endovascular stroke interventions across multiple stroke centers in Germany. It collects comprehensive data on patient demographics, clinical assessments, procedural details, and follow-up outcomes for up to 90 days post-stroke. The study aims to gather real-world evidence on the effectiveness and safety of endovascular treatments for acute ischemic stroke. Data is collected as part of routine clinical care, ensuring a robust dataset for analysis.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years with a clinical diagnosis of acute ischemic stroke who are eligible for intravenous thrombolysis.
Not a fit: Patients who do not have a confirmed diagnosis of persistent occlusion of relevant arteries or those who are not eligible for intravenous thrombolysis may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could improve understanding of endovascular treatment outcomes, leading to enhanced patient care and treatment protocols for acute ischemic stroke.
How similar studies have performed: Other observational studies on endovascular treatments for acute ischemic stroke have shown promising results, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of acute ischemic stroke * Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset * Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms * Age \>18 years * Ethic approval in process Exclusion Criteria: none
Where this trial is running
Hamburg, Free and Hanseatic City of Hamburg
- University Medical Center Hamburg-Eppendorf (UKE) — Hamburg, Free and Hanseatic City of Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Martin Dichgans, Prof. Dr. med. — LMU, Munich, Germany
- Study coordinator: Maximilian Schell
- Email: m.schell@uke.de
- Phone: +49 (0)1522/2834807
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.